Alzheimer's disease (AD) causes gradual cognitive decline and dementia.
Until recently, the definitive diagnosis of AD was based on autopsy assessments of brain amyloid-β plaques and tau neurofibrillary tangles, the defining biological features of AD. Biomarkers of amyloid-β and tau are vital for measuring AD pathology in living people and for differentiating between different neurodegenerative diseases.
With the latest progress in AD research, accurate in-vivo diagnosis of AD is becoming increasingly crucial: before starting treatment with anti-amyloid therapies, it's essential to determine if amyloid positivity is present. This article...
What is Alzheimers Disease in Telugu || Symptoms of Dementia and Alzheimers || Prathima Hospitals || Alzheimer's disease signs || dementia symptoms || Alzheimer's...
"Alzheimer : jour après jour, leur parent les oublie…" est disponible en podcast sur toutes les plateformes.
📚 Ça commence aujourd’hui c’est aussi en livre...
The field of Alzheimer’s disease is evolving rapidly, and laboratory testing is now playing a major role in diagnosis and treatment decisions. Early, accurate...
Learn how neuroinflammation reactions affect Alzheimer’s disease progression.
To learn more about Alzheimer’s disease and access the full activity, visit PeerView.com/AFJ865.
source
What is the history and science of Alzheimer’s disease?
Lori La Bey talks with Dr Michael Hornberger, a Professor of Applied Dementia Research at the...